REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,100
+40 (0.36%)
Last updated: Apr 24, 2026, 3:00 PM KST
Market Cap202.85B -4.6%
Revenue (ttm)145.93B -1.6%
Net Income-29.63B
EPS-1,616.00
Shares Out18.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,083
Average Volume38,648
Open10,980
Previous Close11,060
Day's Range10,850 - 11,300
52-Week Range9,580 - 14,430
Beta0.56
RSI65.89
Earnings DateMay 15, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 448
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

Financial Statements